HomeGANX • NASDAQ
add
Gain Therapeutics Inc
Previous close
$1.94
Day range
$1.93 - $2.03
Year range
$1.41 - $4.34
Market cap
84.08M USD
Avg Volume
840.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.15M | 0.57% |
Net income | -4.54M | -20.42% |
Net profit margin | — | — |
Earnings per share | -0.11 | -37.50% |
EBITDA | -4.46M | -34.06% |
Effective tax rate | -1.57% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.84M | 100.63% |
Total assets | 22.82M | 88.22% |
Total liabilities | 4.25M | -11.08% |
Total equity | 18.56M | — |
Shares outstanding | 42.24M | — |
Price to book | 4.41 | — |
Return on assets | -66.16% | — |
Return on capital | -86.61% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.54M | -20.42% |
Cash from operations | -4.62M | -33.69% |
Cash from investing | — | — |
Cash from financing | 16.55M | 615.62% |
Net change in cash | 12.03M | 822.19% |
Free cash flow | -2.85M | -51.22% |
About
Founded
2017
Website
Employees
20
